Biomarker can help predict preeclampsia risk in women with sickle cell disease

In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring levels of a protein associated with placental function and development.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup